Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Current Opinion in HIV and AIDS was launched in 2006. It antiretroviral therapy in primary HIV infection. Initially is one of a successful series of review journals whose this included an open non-randomised UK study inves- unique format is designed to provide a systematic and tigating the immunological and virological outcome critical assessment of the literature as presented in the comparing early short course ART treatment with no many primary journals. The fields of HIV and AIDS are therapy in individuals presenting with PHI. Based on divided into 6 sections that are reviewed once a year. the results of this pilot work a multi-centered inter- Each section is assigned a Section Editor, a leading national randomised controlled trial (RCT) SPARTAC authority in the area, who identifies the most important is in place, led by Dr Sarah Fidler as the trial physician. topics at that time. Here we are pleased to introduce the She has taken part in international workshops on Section Editor for this issue. primary HIV infection and has presented and chaired debates at national and international conferences. Dr Fidler also has a specialized interest in the factors Section Editor that affect sexual transmission of HIV correlates of Sarah Fidler apparent natural protection against HIV acquisition amongst individuals exposed to HIV yet remaining Sarah Fidler, MBBS, PhD, uninfected. Through this work, funded by NIH-CHAVI has worked as a clinician collaboration she has worked on developing a risk and clinical researcher for algorithm to characterize HIV exposure risk and has the past 10 years in the field recruited HIV serodiscordant couples for immuno- of HIV and sexual trans- logical genetic and virological investigations. The role mission of infection. She stu- of ART as prevention of HIV transmission at a popu- died for a PhD in 1998 in lation level has become a more recent area of interest. HIV immunology at Imper- Dr Fidler has attended recent consultations at the ial College London and con- World Health Organisation discussing the operational tinues to work as an NHS feasibility practical and ethical and human rights issues clinician in addition to run- surrounding ART as prevention, and has been working ning HIV clinical trials based with an international team to develop a research trial to at Imperial College London. test the strategy of treatment for prevention. She has published in the field of PHI and sexual transmission of Dr Fidler’s research has focused on primary HIV infec- HIV has been an elected executive member of the tion, the immunological and virological pathogenesis of British HIV association. earlyHIV infection, andmorerecentlyonthe role of Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Current Opinion in HIV and Aids – Wolters Kluwer Health
Published: Jul 1, 2010
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.